Cargando…

Treatment of erythrodermic psoriasis with apremilast

Detalles Bibliográficos
Autores principales:	Gioe, Olivia A., Savoie, Caroline, Grieshaber, Elizabeth B., Hilton, Deborah C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054184/ https://www.ncbi.nlm.nih.gov/pubmed/33898682 http://dx.doi.org/10.1016/j.jdcr.2021.03.011

Ejemplares similares

Erythrodermic Psoriasis Treated with Apremilast
por: Arcilla, John, et al.
Publicado: (2016)

A case of erythrodermic psoriasis successfully treated with apremilast
por: Megna, Matteo, et al.
Publicado: (2021)

Updates on the Treatment of Erythrodermic Psoriasis
por: Lo, Yang, et al.
Publicado: (2021)

Tildrakizumab: A new therapeutic option for erythrodermic psoriasis?
por: Megna, Matteo, et al.
Publicado: (2021)

Erythrodermic Psoriasis Exacerbated by Bupropion
por: Foss, Michael G, et al.
Publicado: (2021)

Erythrodermic Psoriasis Managed with Risankizumab
por: Alajlan, Abdulmajeed, et al.
Publicado: (2022)

Erythrodermic psoriasis improved by Tildrakizumab
por: Trevisan, Giampaolo, et al.
Publicado: (2022)

Sub‐erythrodermic psoriasis successfully treated with bimekizumab: A case report
por: Valenti, Mario, et al.
Publicado: (2022)

Erythrodermic Psoriasis Improved by Ustekinumab: A Report of Two Cases
por: Kim, Ye Seul, et al.
Publicado: (2016)

Erythrodermic psoriasis: pathophysiology and current treatment perspectives
por: Singh, Rasnik K, et al.
Publicado: (2016)

Erythrodermic Psoriasis Following SARS-CoV-2 Infection
por: Fatima-Zahra, A., et al.
Publicado: (2022)

Apremilast in the Treatment of Plaque Psoriasis: Differential Use in Psoriasis
por: Gao, Jia C, et al.
Publicado: (2022)

Erythrodermic psoriasis after discontinuation of ixekizumab
por: Potter, Kathryn Anne, et al.
Publicado: (2017)

The Management of Erythrodermic Psoriasis Complicated by Cyclosporine
por: Rao, Suman, et al.
Publicado: (2020)

Organizing Pneumonia Complicated with Erythrodermic Psoriasis
por: Nakamura, Hiroyuki, et al.
Publicado: (2019)

Low-dose Naltrexone: An Alternative Treatment for Erythrodermic Psoriasis
por: Beltran Monasterio, Eduardo P
Publicado: (2019)

Effectiveness and safety of infliximab for 11 years in a patient with erythrodermic psoriasis and psoriatic arthritis
por: Trídico, Lívia Arroyo, et al.
Publicado: (2017)

Erythrodermic psoriasis de novo versus skin lesions in chronic lymphocytic leukaemia
por: Słomiak-Wąsik, Anna, et al.
Publicado: (2020)

Pediatric psoriasis treated with apremilast
por: Smith, Rebecca L.
Publicado: (2016)

Respiratory Distress Syndrome Associated with Erythrodermic Psoriasis
por: Noure, Lamya, et al.
Publicado: (2021)

Erythroderme Psoriasis nach COVID-19-Erkrankung
por: Demiri, Jeta, et al.
Publicado: (2021)

Erythroderme Psoriasis nach COVID-19-Erkrankung
por: Demiri, Jeta, et al.
Publicado: (2022)

Erythrodermic psoriasis after COVID-19 vaccination
por: Trepanowski, Nicole, et al.
Publicado: (2022)

Two cases of Erythrodermic psoriasis treated with Golimumab
por: Kudsi, Mayssoun, et al.
Publicado: (2022)

Biologics for the Management of Erythrodermic Psoriasis: An Updated Review
por: Potestio, Luca, et al.
Publicado: (2023)

Treatment Response of Patients with Erythrodermic Psoriasis after Switching to Guselkumab
por: Chiang, Cheng-Ying, et al.
Publicado: (2021)

Treatment of Erythrodermic Psoriasis in Children with Secukinumab: A Case Report
por: Lu, Xujun, et al.
Publicado: (2023)

Phosphodiesterase 4 inhibitor apremilast improves insulin resistance in psoriasis patients
por: Ikumi, Kyoko, et al.
Publicado: (2021)

Apremilast or Methotrexate: The Arrows in the Quiver for Psoriasis
por: Panda, Gautam, et al.
Publicado: (2023)

Characteristics of Patients with Psoriasis Treated with Apremilast in the Corrona Psoriasis Registry
por: Gottlieb, Alice B., et al.
Publicado: (2021)

Update on the treatment of psoriasis and psoriatic arthritis – role of apremilast
por: Forchhammer, Stephan, et al.
Publicado: (2015)

Erythrodermic Psoriasis Treated with Golimumab: A Case Report
por: Lee, Won-Ku, et al.
Publicado: (2015)

Erythrodermic presentation of psoriasis in a patient treated with dupilumab
por: Tracey, Elisabeth H., et al.
Publicado: (2018)

Erythrodermic Psoriasis Causing Uric Acid Crystal Nephropathy
por: Ellis, John, et al.
Publicado: (2019)

Erythrodermic psoriasis in post-coronavirus disease 2019 patient
por: Batubara, Irwan Saputra, et al.
Publicado: (2022)

Ixekizumab for the treatment of erythrodermic psoriasis triggered by durvalumabtremelimumab in a cancer patient
por: Vinaixa Aranzazu, Arrieta, et al.
Publicado: (2021)

Erythrodermic psoriasis with bullous pemphigoid: combination treatment with methotrexate and compound glycyrrhizin
por: Si, Xiaoqing, et al.
Publicado: (2014)

An Uncommon Presentation of Erythrodermic Psoriasis in a Patient Without a History of Psoriasis
por: Rendo, Matt, et al.
Publicado: (2019)

Selective Phosphodiesterase Inhibitors for Psoriasis: Focus on Apremilast
por: Gooderham, Melinda, et al.
Publicado: (2015)

Recurrence of Melanoma after Starting Apremilast for Psoriasis
por: Salopek, Thomas G.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_j4a099vhpdn397v9qgkh2hutfh